Liberalizing Potassium Restrictions in Patients Receiving Hemodialysis

(LIBERATE-K HD Trial)

JA
AS
Overseen ByArti Sharma Parpia, MSc, RD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Ontario Institute of Technology
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

People with end-stage kidney disease who receive hemodialysis are often told to strictly limit foods high in potassium, such as fruits, vegetables, legumes, nuts, and whole grains. This advice is intended to prevent high blood potassium levels (hyperkalemia), which can cause dangerous heart rhythm problems. However, these restrictions can make eating difficult, reduce diet quality, and lower quality of life. New research suggests that not all sources of potassium affect the body in the same way. Potassium added to highly processed foods is more easily absorbed than potassium naturally found in whole foods like fruits and vegetables. Large studies have found little evidence that eating potassium-rich whole foods increases blood potassium levels in people on dialysis. Clinical guidelines are beginning to shift, but no high-quality clinical trial has tested whether a more flexible, food-based approach is safe for people receiving hemodialysis. This study will compare two dietary approaches in 148 adults on hemodialysis: the usual low potassium diet and a "liberalized" potassium diet that encourages minimally processed foods while limiting highly processed foods with potassium additives. Participants will receive dietitian support and grocery assistance for 12 weeks. The investigators will closely monitor blood potassium levels to ensure safety. The investigators will also examine whether the liberalized diet is as safe as standard care, and whether it improves diet quality and quality of life. The investigators will also study factors that influence the participant's ability to follow the diet in real-world settings. If safe, this approach could reduce unnecessary food restrictions, improve diet quality, and enhance quality of life for people receiving hemodialysis, while maintaining patient safety.

Who Is on the Research Team?

JA

JoAnne Arcand, PhD, RD

Principal Investigator

University of Ontario Institute of Technology

RW

Ron Wald, MD

Principal Investigator

Unity Health Toronto

Are You a Good Fit for This Trial?

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Liberalized Potassium DietExperimental Treatment1 Intervention
Group II: Low Potassium DietActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Ontario Institute of Technology

Lead Sponsor

Trials
10
Recruited
10,400+

Unity Health Toronto

Collaborator

Trials
572
Recruited
470,000+